Revenue: The sum of all revenue fields included for a company's operating activities.
Omega Therapeutics, Inc. (OMGAQ) had Revenue of $3.09M for the most recently reported fiscal year, ending 2023-12-31.
| Income Statement Financials | |
|
Revenue |
$3.09M |
$-97.43M |
|
-- |
|
$3.09M |
|
$103.36M |
|
$-100.26M |
|
$2.83M |
|
$-97.43M |
|
$-97.43M |
|
$-97.43M |
|
$-97.43M |
|
$-97.43M |
|
$-97.43M |
|
$-100.26M |
|
$-93.44M |
|
54.01M |
|
54.01M |
|
$-1.80 |
|
$-1.80 |
|
| Balance Sheet Financials | |
$89.88M |
|
$5.31M |
|
$114.48M |
|
$204.37M |
|
$26.81M |
|
$14.88M |
|
$119.54M |
|
$146.35M |
|
$58.02M |
|
$58.02M |
|
$58.02M |
|
55.15M |
|
| Cash Flow Statement Financials | |
$-91.51M |
|
$47.52M |
|
$41.82M |
|
$70.96M |
|
$68.78M |
|
$-2.17M |
|
$8.79M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.35 |
|
-- |
|
-- |
|
0.20 |
|
0.33 |
|
100.00% |
|
-3240.50% |
|
-3240.50% |
|
-3019.94% |
|
-3148.93% |
|
-3148.93% |
|
$-93.73M |
|
-- |
|
-- |
|
-- |
|
0.02 |
|
-- |
|
0.50 |
|
723.28 |
|
-167.93% |
|
-167.93% |
|
-47.67% |
|
-133.64% |
|
$1.05 |
|
$-1.74 |
|
$-1.69 |
|